Lapatinib Active Not Recruiting Phase 2 Trials for HER2/Neu Positive / Geriatric Health Services / Neoplasms, Breast Treatment

Active Not RecruitingTreatment2 IdentifierTitleDrugs
NCT01273610Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Age 60 or Older With HER2 Positive Locally Advanced or Metastatic Breast Cancer
NCT00444535Lapatinib and Bevacizumab for Metastatic Breast Cancer
NCT02213042Evaluation of Biomarkers Associated With Response to Subsequent Therapies in Subjects With HER2-Positive Metastatic Breast Cancer